New technologies delivered to your inbox Subscribe
Browse by Collection
Browse by Category
- Information and Communications
- Physical Sciences
- Life Sciences
NUS Industry Liaison Office (ILO) is the technology translation and commercialization arm of NUS. Over the last five years, ILO has played a pivotal role in getting more than 400 patents granted and more than 55 technology-based companies being spunoff from NUS. In addition to managing and commercializing NUS’ intellectual assets, ILO leverages its deep industry knowledge and network to build strong bonds in numerous technical domains.
Technologies are searchable by category, key word, or phrase and include a detailed description of the technology, inventor and patent information, and contact information to learn more about each technology.
Our available technologies are updated periodically but please feel free contact firstname.lastname@example.org for additional technologies and information.
16047 – Therapeutic Sall4 peptide Technology Overview SALL 4 is an embryonic transcription factor not expressed in normal adult cells but has aberrant expression in leukemia and solid tumor cancers, especially in hepatocellular carcinoma (HCC). SALL4 helps to mediate the repression of PTEN, a tumor suppressor gene, through its interaction with the nucleosome remodeling and deacetylase... Read More
2017-116-nano – Nano Cell Vesicles for Drug Delivery Technology Overview Nano Cell Vesicle Technologies ( nCVTS) are a cell based drug delivery system that utilize the intrinsic targeting abilities of macrophages and monocytes to deliver therapeutics to tumour sites with reduced collateral damage to surrounding healthy tissues. NUS Technology nCVTs are produced from the modification of... Read More
13140 – Mesenchymal stem cell (MSC) osteoprogenitors for regenerative medicine (Ref: 13140) Executive summary Technology overview During production of mesenchymal stromal cells (“MSC”) for human use, in vitro culture typically produces a heterogeneous population of cells which have different biological properties such that the therapeutic outcomes can be vastly different. The... Read More
2017-116 – Micro Cell Vesicles as A Transfection Tools Technology Overview Transfection of certain cell types including stem cells and primary cells such as adipocytes often face issues of low transfection efficiency or high toxicity. Micro Cell vesicles (mCVTs) are able to transfect these cell types with improved transfection efficacy and reduced toxicity. Figure 1. Fusion of lipids with... Read More
12294n – MARKET OPPORTUNITY The global neuropathic pain market was valued at US$ 5.4 Bn in 2016. The market is projected to expand at a CAGR of 5.6% during an eight-year forecast period 2016–2024 and reach US$ 8.3 Bn by the end of 2024 and the Chemotherapy Induced Peripheral Neuropathy segment is estimated to account for 42.4% revenue share in the global neuropathic pain market by 2016 end. ... Read More
2017-212 – MARKET OPPORTUNITY The global organ-on-chip market is expected to grow at a compound annual growth rate of around 69.4% over the next decade to reach approximately $6.13 billion by 2025. Some of the prominent trends include growing applications across several industries and increasing demand in drug screening. TECHNOLOGY This is a modular microfluidics device that allows easy... Read More
13398n – Broadly Neutralizing Monoclonal Antibody against Multiple Influenza A H5Nx clades Market Opportunity Highly pathogenic avian influenza A (HPAI) virus H5N1 remains a serious threat to global health due to its unabated and widespread geographical circulation. WHO reported a high mortality rate of H5N1 infection – 59%. Although human cases remain sporadic, the absence of human herd... Read More
2017-030 – Development of Microneedle Granules and the Application in Drug Delivery Sun Yuanyuan, Kang Lifeng Department of Pharmacy, NUS Microneedles Advantages of MN array over Hypodermic Needles Shortcomings of Current Microneedles for Transdermal drug delivery The concept of Microneedle Granule Bio-inspired structure Applications Topical... Read More
11205n – A Novel Multi-focal Contact Lens to Slow Myopia Progression Applications Patents Opportunity Contact ILO Ref: 11205N Dr Cairan He (email@example.com) Industry Liaison Office, NUS Enterprise Inventor: Prof. Saw Seang Mei Advantages Technology Overview Recent studies in animal have shown single- vision contact lenses (CLs) or... Read More
Surface Coating with Controlled and Sustained Silver Release for Long-term Inhibition of Infection and Encrustation
13185n – Surface Coating with Controlled and Sustained Silver Release for Long-term Inhibition of Infection and Encrustation Applications Patent Opportunity Contact ILO Ref: 13185 Dr Cairan He (firstname.lastname@example.org) Industry Liaison Office, NUS Enterprise Inventor: Prof. Koon Gee Neoh Advantages Technology Overview Urinary tract infections... Read More